BIIB

BIIB

Biogen Inc
Biotechnology
$218.43 -1.68% As of Oct 9, 1:04 AM
Loading chart...
Interactive chart powered by TradingView

Technical Analysis

Negative Divergence: BIIB MACD Rolls Over at $218.43

Bearish
Oct 9, 2026 at 1:04 AM • $218.43 (-1.68%)

Biogen Inc (BIIB) retreated 1.68%, ending the session at $218.43 on October 9.

The technical setup looks bearish:

Moving Averages Mixed signals with price near the 9-day EMA ($222.23). The 21-day EMA sits at $221.48.
Momentum RSI at 46.6 is neutral but weakening. MACD reads 1.53 against its 2.41 signal line (bearish).
Volatility Volatility has been compressing for 3 sessions (TTM Squeeze active), often a precursor to directional moves.

Traders are watching $213.29 on the downside and $230.57 on the upside.

BIIB MACD Death Cross Forms at $218.43

Bearish
Oct 8, 2026 at 9:01 PM • $218.43 (-1.68%)

BIIB Sees Bearish MACD Divergence at $222.15

Bearish
Oct 7, 2026 at 9:01 PM • $222.15 (-0.34%)

Technical Momentum Favors BIIB Bears at $222.89

Bearish
Oct 6, 2026 at 9:02 PM • $222.89 (-0.32%)

BIIB Technical Picture Brightens at $223.59

Bullish
Oct 6, 2026 at 5:26 AM • $223.59 (+1.69%)
Systematic technical analysis • Updated daily after market close

Get Trade Alerts

Receive disciplined options trade ideas with entries, targets & risk management.

Subscribe Now Try Scanner

Market Summary

Current Price $218.43
Daily Change -1.68%
Sentiment Bearish
Sector Biotechnology
Last Updated Oct 9

Related Stocks

ABBV
ABBV
AbbVie Inc
AMGN
AMGN
Amgen Inc
MRNA
MRNA
Moderna Inc
REGN
REGN
Regeneron Pharmaceuticals Inc
VRTX
VRTX
Vertex Pharmaceuticals Inc
Disclaimer: This analysis is for educational purposes only. Options trading involves substantial risk. Past performance does not guarantee future results.